We support clients in the development, execution, and dissemination of the clinical
and economic evidence to ensure effective patient access.
Our clients are dedicated to developing life-saving innovations for patients who need them most, and we’re committed to supporting their evidence generation journey. The right health economic & outcomes research (HEOR) support can not only accelerate go-to-market efforts for the best innovations – it can break down barriers to patient access and communicate value to private and public payers.
We empower our clients with the data and insights to establish your value narrative. Through our HEOR services, we support clients in the development, execution, and dissemination of the clinical and economic evidence to ensure effective patient access to life-saving treatment in the biotechnology space.
Our team of experienced health economists, epidemiologists, and data scientists have significant experience in applying advanced economic methods to effectively capture all dimensions of value of healthcare innovations. We work with our clients to ensure that the manufacturers effectively communicate value and maximize patient access.
Our services also include high-level support for responding to ICER reviews and health technology assessments for US-based and international clients, to optimize performance and increase the likelihood of approval.
